Surgery pp 1827-1838 | Cite as

Transplantation of the Intestine

  • Fady M. Kaldas
  • Douglas G. Farmer


The intestine was one of the last solid organs to be successfully transplanted. The reasons behind the barriers to successful intestinal transplantation (ITx) in humans are multifactorial. No doubt, the fact that the bowel is one of the largest and most active immune “organs” in the human body and the fact that bacteria and fungi reside in symbiosis within the lumen of the gut play a significant role. In fact, the immunogenicity of the intestine is so strong that successful transplantation was not possible without the advent of powerful immunosuppressive medications. This chapter outlines the development of this field, the surgical techniques used, the outcomes, as well as the major problems commonly seen after ITx.


Transplant Proc Intestinal Transplantation Intestinal Failure Small Bowel Transplant Intestinal Graft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lillehei RC, Goott B, Miller FA. The physiological response of the small bowel of the dog to ischemia including prolonged in vitro preservation of the bowel with successful replacement and survival. Ann Surg 1959;150:543–560.PubMedCrossRefGoogle Scholar
  2. 2.
    Starzl TE, Kaupp HA Jr, Brock DR, et al. Homotransplantation of multiple visceral organs. Am J Surg 1962;103:219–229.PubMedCrossRefGoogle Scholar
  3. 3.
    Fishbein TM, Gondolesi GE, Kaufman SS. Intestinal transplantation for gut failure. Gastroenterology 2003;124:1615–1628.PubMedCrossRefGoogle Scholar
  4. 4.
    Langnas AN. Advances in small-intestine transplantation. Transplantation 2004;77(9 suppl):S75–S78.PubMedCrossRefGoogle Scholar
  5. 5.
    Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 1968;64:134–142.PubMedGoogle Scholar
  6. 6.
    Broviac JW, Scribner BH. Prolonged parenteral nutrition in the home. Surg Gynecol Obstet 1974;139:24–28.PubMedGoogle Scholar
  7. 7.
    Calne RY, Rolles K, White DJ, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979;2:1033–1036.PubMedCrossRefGoogle Scholar
  8. 8.
    Grant D, Wall W, Mimeault R, et al. Successful small-bowel/liver transplantation. Lancet 1990;335:181–184.PubMedCrossRefGoogle Scholar
  9. 9.
    Starzl TE, Rowe MI, Todo S, et al. Transplantation of multiple abdominal viscera. JAMA 1989;261:1449–1457.PubMedCrossRefGoogle Scholar
  10. 10.
    Williams JW, Sankary HN, Foster PF, et al. Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease. JAMA 1989;261:1458–1462.PubMedCrossRefGoogle Scholar
  11. 11.
    Goulet O, Jan D, Sarnacki S, et al. Isolated and combined liver-small bowel transplantation in Paris: 1987–1995. Transplant Proc 1996;28:2750.PubMedGoogle Scholar
  12. 12.
    Deltz E, Schroeder P, Gundlach M, et al. Successful clinical small-bowel transplantation. Transplant Proc 1990;22:2501.PubMedGoogle Scholar
  13. 13.
    Abu-Elmagd K, Bond G, Reyes J, Fung J. Intestinal transplantation: a coming of age. Adv Surg 2002;36:65–101.PubMedGoogle Scholar
  14. 14.
    Grant D, Abu-Elmagd K, Reyes J, et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 2005;241:607–613.PubMedCrossRefGoogle Scholar
  15. 15.
    Kaufman SS, Atkinson JB, Bianchi A, et al. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant 2001;5:80–87.PubMedCrossRefGoogle Scholar
  16. 16.
    Reyes J, Mazariegos GV, Bond GM, et al. Pediatric intestinal transplantation: historical notes, principles and controversies. Pediatr Transplant 2002;6:193–207.PubMedCrossRefGoogle Scholar
  17. 17.
    Sudan DL, Kaufman SS, Shaw BW Jr, et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol 2000;95:1506–1515.PubMedCrossRefGoogle Scholar
  18. 18.
    Messing B, Crenn P, Beau P, et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999;117:1043–1050.PubMedCrossRefGoogle Scholar
  19. 19.
    Dorney SF, Ament ME, Berquist WE, et al. Improved survival in very short small bowel of infancy with use of long-term parenteral nutrition. J Pediatr 1985;107:521–525.PubMedCrossRefGoogle Scholar
  20. 20.
    Fryer J, Pellar S, Ormond D, et al. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl 2003;9:748–753.PubMedCrossRefGoogle Scholar
  21. 21.
    Horslen S. Organ allocation for liver-intestine candidates. Liver Transpl 2004;10(10 suppl 2):S86–S89.PubMedCrossRefGoogle Scholar
  22. 22.
    McDiarmid SV, Anand R, Lindblad AS. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002;74:173–181.PubMedCrossRefGoogle Scholar
  23. 23.
    de Ville de Goyet J, Mitchell A, Mayer AD, et al. En block combined reduced-liver and small bowel transplants: from large donors to small children. Transplantation 2000;69:555–559.CrossRefGoogle Scholar
  24. 24.
    The Intestinal Transplant Registry, http://www.intestinal/, Current Results, Intestinal Transplant Registry Final Summary 2003. Accessed 2006.Google Scholar
  25. 25.
    Kato T, Ruiz P, Thompson JF, et al. Intestinal and multivisceral transplantation. World J Surg 2002;26:226–237.PubMedCrossRefGoogle Scholar
  26. 26.
    Sudan DL, Iyer KR, Deroover A, et al. A new technique for combined liver/small intestinal transplantation. Transplantation 2001;72:1846–1848.PubMedCrossRefGoogle Scholar
  27. 27.
    Abu-Elmagd K, Bond G, Reyes J, Fung J. Intestinal Transplantation: Coming of Age, Vol. 36. Mosby; 2002.Google Scholar
  28. 28.
    Horslen SP, Sudan DL, Iyer KR, et al. Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome. Ann Surg 2002;235:435–439.PubMedCrossRefGoogle Scholar
  29. 29.
    U.S. Department of Human Services, Health Resources and Services Administration’s Division of Transplantation 2006 OPTN/SRTR Annual Report: Transplant Data 1996–2005, http://www/ Survival Rate Data Tables. Accessed 2006.Google Scholar
  30. 30.
    Carlsen BT, Farmer DG, Busuttil RW, Miller TA, Rudkin GH. Incidence and management of abdominal wall defects after intestinal and multi visceral transplantation. Plast Reconstr Surg 2007;119:1247–1255; discussion 1256–1258.PubMedCrossRefGoogle Scholar
  31. 31.
    Tzakis AG, Tryphonopoulos P, Kato T, et al. Intestinal transplantation: advances in immunosuppression and surgical techniques. Transplant Proc 2003;35:1925–1926.PubMedCrossRefGoogle Scholar
  32. 32.
    Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998;186:512–525; discussion 525–527.PubMedCrossRefGoogle Scholar
  33. 33.
    Tzakis AG, Nery JR, Thompson J, et al. New immunosuppressive regimens in clinical intestinal transplantation. Transplant Proc 1997;29:683–685.PubMedCrossRefGoogle Scholar
  34. 34.
    Grant D. Oral presentation, Eighth International Small Bowel Transplant Symposium; September 23, 2003; Miami, FL.Google Scholar
  35. 35.
    Farmer DG. Clinical immunosuppression for intestinal transplantation. Curr Opin Organ Transplant 2004;9:214–219.CrossRefGoogle Scholar
  36. 36.
    Ricordi C, Karatzas T, Nery J, et al. High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. Transplantation 1997;63:7–11.PubMedCrossRefGoogle Scholar
  37. 37.
    Salgar SK, Shapiro R, Dodson F, et al. Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol 1999;66:310–314.PubMedGoogle Scholar
  38. 38.
    Abu-Elmagd K, Fung J, McGhee W, et al. The efficacy of dacli-zumab for intestinal transplantation: preliminary report. Transplant Proc 2000;32:1195–1196.PubMedCrossRefGoogle Scholar
  39. 39.
    Carreno MR, Kato T, Weppler D, et al. Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants. Transplant Proc 2001;33:1015–1017.PubMedCrossRefGoogle Scholar
  40. 40.
    Sudan DL, Chinnakotla S, Horslen S, et al. Basiliximab decreases the incidence of acute rejection after intestinal transplantation. Transplant Proc 2002;34:940–941.PubMedCrossRefGoogle Scholar
  41. 41.
    Farmer DG, McDiarmid SV, Edelstein S, et al. Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function. Transplant Proc 2004;36:331–332.PubMedCrossRefGoogle Scholar
  42. 42.
    Gaber AO, First MR, Tesi RJ, et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 1998;66:29–37.PubMedCrossRefGoogle Scholar
  43. 43.
    Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003;361:1502–1510.PubMedCrossRefGoogle Scholar
  44. 44.
    Fung J, Marcos A. Rapamycin: friend, foe, or misunderstood? Liver Transpl 2003;9:469–472.PubMedCrossRefGoogle Scholar
  45. 45.
    Calne R, Friend P, Moffatt S, et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998;351:1701–1702.PubMedCrossRefGoogle Scholar
  46. 46.
    Grant D. Current results of intestinal transplantation. The International Intestinal Transplant Registry. Lancet 1996;347:1801–1803.PubMedCrossRefGoogle Scholar
  47. 47.
    Grant D. Intestinal transplantation: 1997 report of the international registry. Intestinal Transplant Registry. Transplantation 1999;67:1061–1064.PubMedCrossRefGoogle Scholar
  48. 48.
    Goulet O, Lacaille F, Colomb V, et al. Intestinal transplantation in children: Paris experience. Transplant Proc 2002;34:1887–1888.PubMedCrossRefGoogle Scholar
  49. 49.
    Fishbein T, Kaufman S, Schiano T, et al. Intestinal and multiorgan transplantation: the Mount Sinai experience. Transplant Proc 2002;34:891–892.PubMedCrossRefGoogle Scholar
  50. 50.
    Fishbein TM, Kaufman SS, Florman SS, et al. Isolated intestinal transplantation: proof of clinical efficacy. Transplantation 2003;76:636–640.PubMedCrossRefGoogle Scholar
  51. 51.
    Farmer DG, McDiarmid SV, Yersiz H, et al. Outcome after intestinal transplantation: results from one center’s 9-year experience. Arch Surg 2001;136:1027–1031; discussion 1031–1032.PubMedCrossRefGoogle Scholar
  52. 52.
    Farmer DG, McDiarmid SV, Edelstein S, et al. Improved outcome after intestinal transplantation at a single institution over 12 years. Transplant Proc 2004;36:303–304.PubMedCrossRefGoogle Scholar
  53. 53.
    Kato T, Gaynor JJ, Selvaggi G, et al. Intestinal transplantation in children: a summary of clinical outcomes and prognostic factors in 108 patients from a single center. J Gastrointest Surg 2005;9:75–89; discussion 89.PubMedCrossRefGoogle Scholar
  54. 54.
    Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 2001;234:404–416; discussion 416–417.PubMedCrossRefGoogle Scholar
  55. 55.
    Garcia M, Weppler D, Mittal N, et al. Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation. Transplant Proc 2004;36:323–324.PubMedCrossRefGoogle Scholar
  56. 56.
    Kaufman SS, Lyden ER, Marks WH, et al. Lack of utility of intestinal fatty acid binding protein levels in predicting intestinal allograft rejection. Transplantation 2001;71:1058–1060.PubMedCrossRefGoogle Scholar
  57. 57.
    Gondolesi G, Fishbein T, Chehade M, et al. Serum citrulline is a potential marker for rejection of intestinal allografts. Transplant Proc 2002;34:918–920.PubMedCrossRefGoogle Scholar
  58. 58.
    Pappas PA, Saudubray JM, Tzakis AG, et al. Serum citrulline as a marker of acute cellular rejection for intestinal transplantation. Transplant Proc 2002;34:915–917.PubMedCrossRefGoogle Scholar
  59. 59.
    McDiarmid SV, Farmer DG, Kuniyoshi JS, et al. Perforin and granzyme B. Cytolytic proteins up-regulated during rejection of rat small intestine allografts. Transplantation 1995;59:762–766.PubMedCrossRefGoogle Scholar
  60. 60.
    Ruiz P, Bagni A, Brown R, et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the Eighth International Small Bowel Transplant Symposium. Transplant Proc 2004;36:335–337.PubMedCrossRefGoogle Scholar
  61. 61.
    Nishida S, Levi D, Kato T, et al. Ninety-five cases of intestinal transplantation at the University of Miami. J Gastrointest Surg 2002;6:233–239.PubMedCrossRefGoogle Scholar
  62. 62.
    Loinaz C, Kato T, Nishida S, et al. Bacterial infections after intestine and multivisceral transplantation. Transplant Proc 2003;35:1929–1930.PubMedCrossRefGoogle Scholar
  63. 63.
    Langnas A, Chinnakotla S, Sudan D, et al. Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001. Transplant Proc 2002;34:958–960.PubMedCrossRefGoogle Scholar
  64. 64.
    Guaraldi G, Cocchi S, De Ruvo N, et al. Outcome, incidence, and timing of infections in small bowel/multivisceral transplantation. Transplant Proc 2004;36:383–385.PubMedCrossRefGoogle Scholar
  65. 65.
    Sigurdsson L, Reyes J, Kocoshis SA, et al. Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. Transplantation 2000;70:302–305.PubMedCrossRefGoogle Scholar
  66. 66.
    Ziring D, Tran R, Edelstein S, et al. Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation 2005;79:702–709.PubMedCrossRefGoogle Scholar
  67. 67.
    Kocoshis SA. Small bowel transplantation in infants and children. Gastroenterol Clin North Am 1994;23:727–742.PubMedGoogle Scholar
  68. 68.
    Bueno J, Green M, Kocoshis S, et al. Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis 1997;25:1078–1083.PubMedCrossRefGoogle Scholar
  69. 69.
    Manez R, Kusne S, Green M, et al. Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995;59:1010–1014.PubMedCrossRefGoogle Scholar
  70. 70.
    Farmer DG, McDiarmid SV, Winston D, et al. Effectiveness of aggressive prophylactic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation. Transplant Proc 2002;34:948–949.PubMedCrossRefGoogle Scholar
  71. 71.
    Rovera GM, Strohm S, Bueno J, et al. Nutritional monitoring of pediatric intestinal transplant recipients. Transplant Proc 1998;30:2519–2520.PubMedCrossRefGoogle Scholar
  72. 72.
    Nucci AM, Reyes J, Yaworski JA, et al. Serum growth factors and growth indices pre-and post-pediatric intestinal transplantation. J Pediatr Surg 2003;38:1043–1047.PubMedCrossRefGoogle Scholar
  73. 73.
    Sudan DL, Iverson A, Weseman RA, et al. Assessment of function, growth and development, and long-term quality of life after small bowel transplantation. Transplant Proc 2000;32:1211–1212.PubMedCrossRefGoogle Scholar
  74. 74.
    Iyer K, Horslen S, Iverson A, et al. Nutritional outcome and growth of children after intestinal transplantation. J Pediatr Surg 2002;37:464–466.PubMedCrossRefGoogle Scholar
  75. 75.
    Cameron EA, Binnie JA, Jamieson NV, et al. Quality of life in adults following small bowel transplantation. Transplant Proc 2002;34:965–966.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Fady M. Kaldas
    • 1
  • Douglas G. Farmer
    • 2
    • 3
    • 4
    • 5
  1. 1.Department of SurgeryUniversity of CaliforniaLos AngelesUSA
  2. 2.Department of SurgeryDavid Geffen School of Medicine at UCLALos AngelesUSA
  3. 3.Intestinal Transplant ProgramDumont UCLA Transplant CenterLos AngelesUSA
  4. 4.Pediatric Liver Transplant ProgramDumont UCLA Transplant CenterLos AngelesUSA
  5. 5.Intestinal Failure Center, Division of Liver and Pancreas TransplantationDumont UCLA Transplant CenterLos AngelesUSA

Personalised recommendations